Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
City to sue Merck, Schering-Plough
The city of New Haven, Connecticut will be suing Merck and Schering-Plough on the basis that Vyotrin doesn't work.
New Haven, which has spent $100,000 shy of a half million dollars on Vytorin and Zetia for employees, will seek reimbursement for the tax money it spent on the medications.
While Merck did not comment, a Schering-Plough spokesperson said the company stood behind its product and would fight any challenge vigorously.
- check out the Pharmalot blog entry
Related Articles:
Analyst gloomy on Merck trends
Congress broadens Vytorin probe
Merck, Schering-Plough stocks take a dive
More bad Vytorin news for Merck, Schering
Vytorin scrips still falling, Hassan hires help
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
